Early Benefit Assessments in Oncology in Germany: How Can a Clinically Relevant Endpoint Not Be Relevant to Patients? Jörg RuofOlivier FlückigerNiko Andre Current Opinion Open access 19 August 2015 Pages: 221 - 226
Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes Valerie VuylstekeLisa M. ChastainCrystal Brown Review Article Open access 08 August 2015 Pages: 227 - 232
Molecular Insight in the Multifunctional Effects of Oridonin Brice Ayissi OwonaHerman J. Schluesener Review Article Open access 20 August 2015 Pages: 233 - 244
Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes Rika ItoTomoyasu FukuiTsutomu Hirano Original Research Article Open access 30 July 2015 Pages: 245 - 251
Stability of Melphalan in 0.9 % Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection Romain-Pacôme DesmarisLionel MercierAngelo Paci Original Research Article Open access 16 July 2015 Pages: 253 - 259
Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment Sivi Ouwerkerk-MahadevanMaria Beumont-MauvielAlexandru Simion Original Research Article Open access 07 August 2015 Pages: 261 - 270
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data Roger A. RodbyKausik UmanathFor the Collaborative Study Group Original Research Article Open access 04 August 2015 Pages: 271 - 279
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial Claire L. AmberyPascal WieldersJohn H. Riley Original Research Article Open access 19 August 2015 Pages: 281 - 291
